CHAD Teams With AirMatrix, ACOBA To Enter Sleep Disorder Market
With companies everywhere expanding into the sleep disorder market, CHAD Therapeutics Inc will not be left behind. The Chatsworth, Calif-based company has entered into product development and license agreements with AirMatrix Technologies Inc and ACOBA LLC. Together, these companies plan to address potential applications in the rapidly growing sleep therapy market and develop technology to expand CHAD’s home and hospital respiratory product lines.

"We are excited about the opportunity to develop technology with the potential to significantly expand and diversify CHAD’s product lines and addressable markets,” says CEO Thomas E. Jones.

This product development program, a joint project between CHAD’s internal product development team and ACOBA, should take 12 to 24 months before the initial products are ready for market introduction, Jones says. Funding will most likely come from cash flow from operations.

Overall, CHAD reported increased revenues and net earnings for the third quarter and first 9 months of fiscal 2003 ended December 31. Jones attributes part of the company’s success to domestic sales of conservers and expects growth earnings to continue to grow for the remainder of this year and in fiscal 2004.

FDA OKs Pegasus CPAP
In January, the US Food and Drug Administration granted 510(k) clearance to the Pegasus CPAP by VIASYS Healthcare Inc’s Respiratory Technologies Group, Yorba Linda, Calif. The Pegasus features a compliance monitoring interface and software.

Braebon Unveils Web Site
To find out why Braebon Medical Corp, Ogdensburg, NY, claims it does “More Than Just Listen,” the company suggests that sleep specialists visit www.braebon.com. The new Web site includes product technical information, events and conferences, information requests, and answers to frequently asked questions. www.braebon.com. 

ResMed’s Godish Joins Innomed
In February, Innomed Technologies Inc, Boca Raton, Fla, appointed Ken Godish to its management team as director of sales and national accounts. He has more than 25 years of marketing and sales management experience in the medical device industry. Since 1992, he worked at ResMed Corp, Poway, Calif, where, as director of sales, Western region, he was responsible for building the western half of the US sales organization and increasing revenues to more than $30 million annually. As ResMed’s director of key accounts, new business development, he was involved in efforts targeting the cardiology and neurology markets.